Celebrities on Weight Loss Drugs
Back to Articles
News6 min readJanuary 29, 2025

Celebrities on Weight Loss Drugs

A look at which celebrities have openly discussed using GLP-1 medications and how it's changing the conversation around weight loss.

By Med Consumer Watch Team
GLP-1 medications like Ozempic, Wegovy, and Mounjaro have become household names, partly due to celebrity attention. Some stars have openly discussed their use, while others face speculation. Here's what we know about celebrities and weight loss medications.

Why Celebrity Use Matters

Celebrity disclosure of medication use has both positive and negative effects: Positive impacts: • Reduces stigma around medical weight management • Raises awareness about available treatments • Normalizes seeking medical help for obesity • Sparks conversations about weight and health Potential downsides: • May create unrealistic expectations about results • Could trivialize serious medical treatment • Increases demand and worsens shortages for diabetic patients • May encourage off-label or inappropriate use

Celebrities Who Have Confirmed Use

Several high-profile individuals have openly discussed using GLP-1 medications: These include various TV personalities, musicians, and public figures who have been transparent about their weight loss journeys involving prescription medications. Some have spoken about using them for diabetes management, while others have discussed weight loss specifically. The transparency from some celebrities has helped destigmatize medical weight management, showing that weight loss isn't always about willpower alone.

Celebrity experiences don't predict individual results. Medical treatments work differently for everyone.

The Speculation Problem

Many celebrities face speculation without confirmation: Why this is problematic: • Invades privacy around medical decisions • Reinforces that thinness requires explanation • Creates pressure to disclose private health information • Perpetuates judgment around weight loss methods What we should remember: • Celebrities aren't obligated to explain their bodies • Speculation is often wrong • All weight loss methods are valid when appropriate • Medical decisions are personal

Impact on Medication Access

Celebrity attention has contributed to: Increased demand: Ozempic and other GLP-1 medications have faced significant shortages, partly driven by increased demand from those seeking weight loss rather than diabetes management. Off-label use surge: Ozempic is approved for diabetes, not weight loss (Wegovy is the weight loss version). Celebrity use has increased off-label prescriptions. Insurance complications: The surge in demand has led some insurers to tighten coverage requirements.

GLP-1 medications should only be used under medical supervision for appropriate indications. Celebrity use doesn't make them safe or appropriate for everyone.

The Bigger Picture

Celebrity disclosure reflects broader societal shifts: • Obesity increasingly recognized as a medical condition • Less shame around medical intervention for weight • Growing acceptance that willpower isn't always enough • More open conversations about body and health While celebrity attention brings awareness, remember that these are serious medications with risks and side effects. What works for a celebrity may not be right for you.

The Bottom Line

Celebrity use of weight loss medications has helped normalize medical weight management while also contributing to supply problems and potentially unrealistic expectations. The most important takeaway isn't which celebrities use these drugs—it's that weight loss medication decisions should be made with healthcare providers based on individual health needs, not celebrity influence.

Sources & References

  • Various Entertainment News Sources
  • FDA Drug Shortage Database

Medical Disclaimer

This article is for informational purposes only and is not intended as medical advice. Always consult with a qualified healthcare provider before making decisions about your health or medications. Individual experiences may vary.